Andy MacKay

Andy Mackay has a strong background in medical information and pharmaceuticals. Andy currently holds the position of Director, Global Medical Information Lead at Idorsia Pharmaceuticals Ltd since August 2023. Prior to that, they worked as the Associate Director Global Medical Information Product Specialist at the same company from March 2023 to August 2023, and as the Global Medical Information Product Specialist from June 2021 to March 2023. Before joining Idorsia Pharmaceuticals Ltd, Andy Mackay worked at Biogen as the Global Medical Information Manager from May 2019 to June 2021. Andy also has experience in global medical affairs at EUSA Pharma as a Global Medical Affairs Associate from May 2018 to April 2019. Prior to that, Andy Mackay worked at Roche as a Medical Information Specialist from June 2015 to April 2018, and at ProPharma Group as a Senior Medical Information Officer from March 2015 to May 2015, and as a Medical Information Officer from March 2014 to March 2015.

Andy Mackay has a Master of Research degree in Biomedical Sciences from the University of Liverpool, which they obtained in the year 2011. Prior to that, they completed their BSc Hons in Biomedical Sciences at Newcastle University from 2006 to 2009. In 2012, they obtained an Introductory Certificate in Marketing from CIM | The Chartered Institute of Marketing. Additionally, they have obtained certifications in Drug Development from the University of California San Diego, Genomic and Precision Medicine from the University of California, San Francisco, and Epigenetic Control of Gene Expression from The University of Melbourne. The specific months of obtaining the certifications are not provided.